Latest Posts
About This Stock
More About This Stock
Read
Read
Read
CARA Announces Positive Top-Line Data From Phase 1b Trial Of IV CR845; PVCT To Sponsor AAPI
![](https://talkmarkets.com/user_content/contacts/thumb_AD8BCD13-22EE-4A01-A8C9-BF6F1B86C661.jpeg?app=196730)
Article By:
BioMedReports
Thursday, December 18, 2014 4:42 AM EDT
CARA a bio-pharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain , PVCT announced it has agreed to sponsor the activities of the American Association of Physicians of Indian Origin.
Medidata Appoints Mike Capone COO; PV-10 Data At Esmo 2014 Show
![](https://talkmarkets.com/user_content/contacts/thumb_AD8BCD13-22EE-4A01-A8C9-BF6F1B86C661.jpeg?app=196730)
Article By:
BioMedReports
Tuesday, September 30, 2014 3:03 AM EDT
Medidata the leading global provider of cloud-based solutions for clinical research in life sciences, announced Michael L. Capone is joining the company as chief operating officer COO.
Provectus Phase III Melanoma Trial Results Earlier Than Planned?
![](https://talkmarkets.com/user_content/contacts/thumb_A2CB0D8A-26C4-4950-AD7B-1178EE855143.jpeg?app=196353)
Article By:
Alan Robert Ross
Tuesday, June 17, 2014 8:42 PM EDT
Based upon pre-existing and clear data on safety & efficacy, it is very likely that the PVCT Phase III pivotal melanoma trial will demonstrate the safety and efficacy of PV-10 to the market and to prospective acquirers earlier than anticipated.
In this article: PVCT
Provectus Phase III Melanoma Trial Results Earlier Than Planned?
Excellent article @[Alan Robert Ross](user:5068)! What are your current feelings on $PVCT?